EUVIMEDEUVIMED entdecken
Crossref

A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants

Matej Andelic, Solveig Skovlund Groen, Jesper Grønlund Holm, Alexander Egeberg, Jacob P Thyssen, Valdemar W Nielsen, Morten Karsdal, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Simon Francis Thomsen

European Journal of Dermatology · 2025

DOI: 10.1684/ejd.2025.4854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2025. Verfasst von Matej Andelic und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Copenhagen, Denmark, Immunoscience, Nordic Bioscience, Herlev, Denmark. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Immunosuppressive Agents, Calcineurin Inhibitors, Collagen Type VII.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicImmunosuppressive AgentsCalcineurin InhibitorsCollagen Type VIINon-Fibrillar CollagensAutoantigensHumansBiomarkersMaleFemaleAdultMiddle AgedSeverity of Illness IndexCollagen Type XVIICase-Control StudiesYoung AdultAdolescent

Stichwörter der Autor:innen

ECMECM remodellingatopic dermatitisbiomarkertype VII collagen

Substanzen

BiomarkersImmunosuppressive AgentsCalcineurin InhibitorsCollagen Type VIICollagen Type XVIINon-Fibrillar CollagensAutoantigens

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Copenhagen, Denmark, Immunoscience, Nordic Bioscience, Herlev, Denmark.
  • Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
  • Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark, Department of Clinical Medicine, University of Copenhagen, Denmark.
  • Immunoscience, Nordic Bioscience, Herlev, Denmark.
  • Department of Biomedical Sciences, University of Copenhagen, Denmark, Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.

Zitieren

APA

Andelic, M., Groen, S. S., Holm, J. G., Egeberg, A., Thyssen, J. P., Nielsen, V. W., Karsdal, M., Bay-Jensen, A. C., Nielsen, S. H., & Thomsen, S. F. (2025). A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants. European Journal of Dermatology. https://doi.org/10.1684/ejd.2025.4854

Vancouver

Andelic M, Groen SS, Holm JG, Egeberg A, Thyssen JP, Nielsen VW, et al. A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants. European Journal of Dermatology. 2025. doi:10.1684/ejd.2025.4854

BibTeX
@article{Andelic2025,
  author = {Andelic, Matej and Groen, Solveig Skovlund and Holm, Jesper Grønlund and Egeberg, Alexander and Thyssen, Jacob P and Nielsen, Valdemar W and Karsdal, Morten and Bay-Jensen, Anne-Christine and Nielsen, Signe Holm and Thomsen, Simon Francis},
  title = {A novel biomarker of type VII collagen degradation increases in patients with atopic dermatitis and decreases upon treatment with immunosuppressants},
  journal = {European Journal of Dermatology},
  year = {2025},
  doi = {10.1684/ejd.2025.4854}
}
Kostenlos starten →